Is Cipher Pharmaceuticals Inc. FDA approved?

Cipher Pharmaceuticals Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Cipher Pharmaceuticals Inc. make?

2 products are listed under Cipher Pharmaceuticals Inc. in the openFDA NDC Directory, most often as suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Cipher Pharmaceuticals Inc.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 2
Live patents: 1
Countries: 0

Catalogue

Drug listings by form and route

2 active NDC listings: 2 human prescription drug. By marketing category: NDA 1, NDA AUTHORIZED GENERIC 1.

Dosage form	NDCs
suspension	2

Route	NDCs
topical	2

Labeller name on the listing	NDCs
cipher pharmaceuticals inc.	2

Exclusivity

Patents and exclusivities

Patent	Product	Covers	Expiry
9895388	NATROBAspinosad	use	Nov 2033

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
Natroba	spinosad	suspension, topical	84635-929NDA
Spinosad	spinosad	suspension, topical	84635-570NDA AUTHORIZED GENERIC

Compare

Other companies listing spinosad

Elanco US Inc.6 sites · 46 NDC
Allegis Pharmaceuticals, Inc.2 sites · 16 NDC
ParaPRO LLC0 sites · 2 NDC

Enquiry

Common questions

Is Cipher Pharmaceuticals Inc. FDA approved?: Cipher Pharmaceuticals Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Cipher Pharmaceuticals Inc. make?: 2 products are listed under Cipher Pharmaceuticals Inc. in the openFDA NDC Directory, most often as suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.